View Author
18ink mutation ret 2b mice p 18ink plasma calcitonin levels p 18ink expression expression tumor cancer mtc development oncogenic ret sample calcitonin development table level plasma sialic acid oncogenic protein analysis medullary thyroid carcinoma month excretion patient urine 12 months cdk 4 method thyroid cycle p 18ink proteins sialic inhibitor quanti netherland quanti fication utrecht concentration p 18ink mutants cdk 6 suppressor carcinoma wildtype result knockout ret 2b mmol /mol creatinine mouse genotype fication genotype groups group disease department p 18 mutations p 18à/à mice incidence tumorigenesi medullary ret mutations mtc incidence 9 months sa metabolism growth progression ink 4 proteins wildtype p 18ink van der ham transfected age-related reference values ret 2b mouse urine samples mutant control creatinine research 18à/à effect 2os cells
3 Most Recent Publications
|
P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development
(Article)
Veelen, W. van Klompmaker, R. Gloerich, M. Gasteren, C.J.R. van Kalkhoven, E. Berger, R. Lips, C.J.M. Medema, R.H. Höppener, J.W.M. Acton, D.S. |
2009-01-15
|
|
Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development
(Article)
Veelen, W. van Gasteren, C.J.R. van Acton, D.S. Franklin, D.S. Berger, R. Lips, C.J.M. Höppener, J.W.M. |
2008-03-01
|
|
Quantification of free and total sialic acid excretion by LC-MS/MS
(Article)
Ham, M. van der Prinsen, B.H. Huijmans, J. Abeling, N.G.G.M. Dorland, B. Berger, R. Koning, T.J. de Sain-van der Velden, M.G.M. de |
2007-04-01
|